Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...

The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive ... it by suppressing further anti-cancer interventions from the immune ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Researchers have identified a surprising mechanism that helps cells defend against cancer, a new study by the Sydney-based ...

First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ImmutepGlobal Phase III with ...

The Hebrew University of Jerusalem proudly extends its heartfelt congratulations to Prof. Yinon Ben-Neriah of the Faculty of ...

Treatment of B-cell acute lymphoblastic leukemia has improved thanks to CAR T therapies, but relapse is still very common. An ...

A growing interest has emerged in natural compounds with potential therapeutic benefits, with ginger (Zingiber officinale) being a notable example ...

To date, the project has successfully developed self-assembled nanoparticles capable of loading and releasing anti-cancer ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...